BRAF Inhibition in a Lung Transplant Recipient With Metastatic Melanoma.
Institute for General Practice, Hannover Medical School, Hannover, Germany.
Kambiz
K
Afshar
Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Sascha
S
David
Department of Pulmonary Medicine, Hannover Medical School, Hannover, Germany.
Thomas
T
Fuehner
Department of Pulmonary Medicine, Hannover Medical School, Hannover, Germany.
Jens
J
Gottlieb
Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.
Ralf
R
Gutzmer
D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000494:pharmacology; D007211:Indoles / Q000008:administration & dosage / Q000494:pharmacology; D016040:Lung Transplantation; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D009362:Neoplasm Metastasis; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors*; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology; D000077484:Vemurafenib
D007166:Immunosuppressive Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf